Our otic, nasal, and inhalation portfolio addresses specialized delivery requirements where formulation performance and manufacturing precision are essential. We apply controlled processes and rigorous quality standards to support consistent product performance across these specialized dosage forms.
Our market-focused approach allows us to develop and supply products suited to different regulatory and commercial environments. By combining technical capabilities with reliable manufacturing, we help partners build differentiated portfolios across respiratory, nasal, and ear-care segments.
| Product | Therapy area |
|---|---|
| Ofloxacin | Otic anti-infective |
| Ciprofloxacin + Dexamethasone | Otic anti-infective |
| Olopatadine HCl | Allergic rhinitis |
| Levalbuterol HCl | Respiratory |
| Tobramycin | Respiratory |
Pharmiqo Pharmacare delivers high-quality sterile injectables crafted with precision, ensuring safety, consistency, and reliable therapeutic performance.
Pharmiqo Pharmacare is a specialized pharmaceutical Tech Transfer partner with a global footprint across the United States, Europe, and India.
Copyright © 2026 Pharmiqo Pharmacare. All Rights Reserved.